Chimeric Antigen Receptor Natural Killer (CAR-NK) cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Chimeric Antigen Receptor Natural Killer (CAR-NK) cell therapy, covering 2025-05-13 to 2025-05-13. Get the full timeline:
Most recent: Clinical Trial Update: Chimeric Antigen Receptor Natural Killer Cell Therapy for High-risk Lymphoma Patients With Primary Sjogren's Syndrome [Phase 1, Phase 2]